Drug Report History #211157

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language (Changed) Updated to: French Was: English
Date Updated (Changed) Updated to: 2025-04-28 Was: 2023-11-22
Drug Identification Number 02429667 02429667
Brand name TAMSULOSIN CR TAMSULOSIN CR
Common or Proper name Tamsulosin Tamsulosin
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients TAMSULOSIN HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500 500
Additional packaging sizes
ATC code G04CA G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-11-18 2023-11-18
Estimated end date (Changed) Updated to: Unknown Was: 2024-01-15
Actual end date (Changed) Updated to: 2024-12-02 Was:
Shortage status (Changed) Updated to: Resolved Was: Actual shortage
Tier 3 Status (Changed) Updated to: Yes Was: No
Company comments
Health Canada comments